A berrant T lymphocyte activity is implicated in the development of graft-versus-host disease, the pathogenesis of diverse autoimmune diseases, the growth of T cell malignancies, and the evolution of organ allograft rejection. Suppression of abnormal T cell responses has relied on pharmacologic agents that interfere with essential cell surface receptors or metabolic pathways of reactive lymphocytes. However, these agents are usually not selective for T cells, and thus their use results in generalized host immunosuppression and other serious side effects. Purine nucleoside phosphorylase (PNP, EC 2.4.2.1) is an enzyme involved in the recycling of nucleosides and deoxynucleosides in cellular remodeling. Although PNP is present in all mammalian cells, T cells are especially sensitive to deficiencies of this enzyme. A rare genetic deficiency of PNP results in a gradual specific loss of T cell function after birth and is associated with significant cellular immunodeficiency (1) . DNA synthesis in other lymphoid and nonlymphoid cells of affected individuals is usually normal, suggesting that inhibition of PNP may provide an effective mechanism for selectively targeting T cells.
Inhibitors of PNP were first developed by using a structurebased inhibitor design focused on iterative group alignment established from the PNP crystal structures (2, 3) . These inhibitors achieved only nanomolar dissociation constants, which limited their effectiveness because greater than 95% continuous inhibition of PNP is required for significant reduction in T cell function (4) . Another approach for designing enzyme inhibitors is based on the identification of the transition-state structure stabilized by the target enzyme. Transition-state analogs preferentially bind their cognate enzyme with high affinity (5-7). The transition-state structure for the arsenolysis of inosine by PNP was used to guide the design of an inhibitor designated Immucillin-H (Imm-H) ( Fig. 1) (6, 8, 9) . This is, to our knowledge, the first report characterizing the biochemical and biologic effects of Imm-H, a picomolar inhibitor of PNP.
Imm-H selectively inhibited the in vitro growth of malignant T cell lines in the presence of deoxyguanosine (dGuo) without affecting non-T cell tumor lines. Activated human peripheral blood T lymphocytes were also sensitive to inhibition by Imm-H. Toxicity in leukemia cells was related to an accumulation of dGTP and the subsequent failure to synthesize cellular DNA. Under normal physiologic conditions, dGuo undergoes phosphorolysis by PNP. However, when PNP is inhibited, deoxycytidine kinase (dCK, EC 2.7.1.74) shunts unmetabolized dGuo into dGTP, which accumulates and blocks DNA synthesis. A correlation between the degree of T cell inhibition and the level of dCK activity was observed. These powerful biological effects of Imm-H suggest that this agent may have utility in the treatment of certain human diseases characterized by abnormal T cell growth or activation.
Materials and Methods
Reagents. Imm-H [(1S)-1-(9-deazahypozanthin-9-yl)-1,4-dideoxy-1,4-imino-D-ribitol] was synthesized from D-gulonolactone and chemically protected 9-deazahypoxanthine (10, 11) . Incorporation of 14 C at the 2 position of the deazahypoxanthine ring was accomplished by including 14 C-formamidine at the appropriate step in the chemical synthesis. Purity and structure were established by NMR, and radiochemical purity was checked by HPLC. Nucleosides and deoxynucleosides were purchased from Sigma. and 100 g͞ml streptomycin (Life Technologies, Gaithersburg, MD). Other tumor cell lines were provided by Bristol-Myers Squibb and were cultured in RPMI medium 1640 supplemented with 10% FBS.
Human Peripheral T Cells. Collection of blood from normal volunteers was performed after obtaining informed consent under a protocol approved by the Committee on Clinical Investigations at the Albert Einstein College of Medicine. Blood was obtained from volunteers, and peripheral blood mononuclear cells (PBMC) were isolated by density gradient centrifugation by using Ficoll͞Hypaque (Amersham Pharmacia, Pharmacia Biotech, Piscataway, NJ). T cells were isolated from PBMC by negative selection by using the Pan T-cell Isolation Kit (Miltenyi Biotec, Auburn, CA). Magnetic bead sorting was accomplished by using an AutoMacs instrument (Miltenyi Biotec) according to the manufacturer's instructions. Isolated T cells were characterized as CD3 ϩ , CD45 ϩ , CD14 Ϫ , and CD16 Ϫ ͞CD56 Ϫ (99%) by FACScan analysis (Becton Dickinson) by using fluorescentlabeled monoclonal antibodies (Becton Dickinson). Viability was assessed by using trypan blue exclusion in cells cultured in DMEM supplemented with 10% FBS͞100 units͞ml penicillin͞ 100 g/ml streptomycin͞2 mM glutamine (Life Technologies) in a humidified 5% atmosphere at 5% CO 2 37°C.
Cell Proliferation Assays. Cell proliferation was measured by a colorimetric assay based on formazan production from tetrazolium salts or standard [ (12) and from previously described methods (13, 14) . This concentration guided the dGuo concentration. Selected samples were stimulated with a mouse anti-human CD3 mAb (0.5 g͞ml) (Ancell, Bayport, MN) and recombinant human IL-2 (rhIL-2, 20 units͞ml). Other samples were incubated for 6 days and stimulated with rhIL-2 (200 units͞ml) and T cell-depleted mononuclear cells (5 ϫ 10 5 cells͞ml) pretreated with 50 g͞ml of mitomycin. All experiments were done in triplicate.
For the colorimetric assay, tetrazolium salt WST-1 was added according to the manufacturer's instructions after 72 h of incubation (Boehringer Mannheim). Absorbance of formazan product was measured at 440 nm, and the fraction of viable cells was calculated as (A at 440 nm sample͞A at 440 nm control). Alternatively, proliferation was measured by [ 3 H]thymidine incorporation where 1 Ci was added to each well, and cells were incubated for another 18 h. Inhibition of DNA synthesis, as detected by thymidine incorporation, is an early event that precedes cell lysis. Formazan formation results from mitochondrial electron transfer, a reaction that persists until mitochondrial lysis. Cells were harvested onto glass fiber filters and analyzed by scintillation counting by using a 1414 Winspectral (Wallac, Gaithersburg, MD). Cell proliferation was measured as (cpm sample͞cpm control). Controls for [ dGuo Accumulation. The CCRF-CEM-cultured T cells were incubated for 24 h in complete medium as described above, containing 10 M dGuo with or without 10 M Imm-H. Cells (5 ϫ 10 6 ) were pelleted, washed once with ice-cold PBS, and lysed with 0.5 M perchloric acid. The supernatant was adjusted to pH 6-8 with 2 M ammonium phosphate and analyzed for dGTP and GTP on a Partsil10 SAX 4.6 ϫ 250 mm column (Millipore) with a gradient of ammonium phosphate (5 mM, pH 2.8, to 750 mM, pH 3.7, 50 min). The quantities of these guanine nucleotides were determined from standards of dGTP and GTP analyzed under similar experimental conditions. H]adenosine. At the indicated times, cells were washed twice with PBS followed by treatment with 1 ml 5% trichloroacetic acid (TCA). The pellets were washed with 5% TCA, solubilized in formic acid and radioactivity measured in a 1414 Winspectral (Wallac).
Imm-H Metabolism. CCRF-CEM cells were incubated under conditions similar to methods described above for cell proliferation assays. Briefly, 1 ϫ 10 6 cells͞ml were incubated for 72 h without dGuo followed by 18-h incubation with 0.5 Ci [2-14 C]Imm-H (50 Ci͞mol). Cells were harvested and analyzed for 14 C incorporation into nucleic acids as described above.
dCK Assay. T cell lines were cultured in RPMI medium 1640 as described above. After 72 h of incubation, 10 7 cells with Ͼ95% viability (by trypan blue exclusion) were washed once with PBS and resuspended in 200 l of 50 mM KPO 4 , pH 7.6, 1 mM DTT, and 10% vol͞vol glycerol. Cells were sonicated for 20 seconds (30% duty cycle), and the lysate was centrifuged at 14,000 ϫ g for 10 min. The supernatant was analyzed for total protein content with the dye-binding assay of Bradford (Bio-Rad) by using BSA as a standard. Extracts were assayed for dCK following previously described methods (15) . Briefly, extracts from 2 ϫ 10 5 and 1 ϫ 10 6 cells were added to reaction mixtures containing 5 M [ 3 H]deoxycytidine, 2 mM ATP, 25 mM MgCl 2 , 0.5 mM cytidine, 0.5 mM deoxyuridine, and 50 mM potassium phosphate, pH 7.6. The mixture was incubated at 37°C, and aliquots were loaded on a 1-ml column of DEAE A-25. The column was washed with 5 volumes of 100 mM ammonium bicarbonate, pH 8.0, to elute deoxynucleosides. dCMP was eluted with five volumes of 1 M ammonium bicarbonate, pH 8.0, and fractions were analyzed for 3 H content in a Wallac 1414 liquid scintillation counter by using Liquiscint (National Diagnostics).
5-Nucleotidase Assay. Initially, 1 ϫ 10 7 cells were cultured in RPMI medium 1640 for 3 days and washed with PBS followed by 0.29 mM sucrose and 10 mM Tris⅐HCl, pH 7.4. The cells were resuspended in sucrose buffer at a concentration of 1 ϫ 10 8 cells͞ml and sonicated twice for 10 seconds at 30% duty cycle. Samples were centrifuged at 100,000 ϫ g for 60 min at 4°C, and supernatant equivalent to 2 ϫ 10 5 and 1 ϫ 10 6 cells was added to reaction mixtures containing 100 mM Tris⅐HCl, pH 7.4, 10 mM MgCl 2 , 3 mM ATP, 500 mM NaCl, 0.4 mM inosine monophosphate (IMP), and 1.25 Ci͞mol [8- The nucleotide͞nucleoside ratio was determined by using DEAE A-25 column analysis as described above for the dCK assay. (Fig. 2B) . These effects were selective for the malignant T cell lines, as proliferation of the human B cell leukemia lines BL2, SKW 4.2 (data not shown), and the human colon carcinoma cell line GEO were not inhibited. Inhibition of PNP has been reported to be toxic to all T cell lines; however, no effect of Imm-H was observed against the Jurkat T cell leukemia line (data not shown) (17, 18) . CCRF-CEM cells could be rescued from Imm-H sensitivity by excluding dGuo from the culture medium or by adding 20 M deoxycytidine (dCyd) in the presence of dGuo (Fig. 2C) . dCyd rescues cells by competing for dGuo phosphorylation and by dCMP product inhibition of dCK (18) . MOLT-4 cells demonstrated a similar pattern (data not shown); toxicity was obviated in the absence of dGuo and was overcome by the addition of dCyd.
Results

Imm-H Inhibits
Imm-H (up to 50 M) had no direct toxic effects when added to cultures of a variety of non-T cell lines derived from various tissues ( Table 1) . Although the IC 50 for T cell lines was near 5 nM, these cell lines tolerated concentrations at least 10 4 times greater. To further define the cytotoxic effects of Imm-H on the CCRF-CEM and MOLT-4 lines, treated cells were analyzed for the induction of apoptosis. Annexin staining revealed significant apoptosis of CCRF-CEM (Fig. 3) and MOLT-4 (data not shown) cells treated with Imm-H and dGuo for 36 h. Apoptosis was not detected in the same cells when 20 M dCyd was added or in the absence of dGuo. Apoptosis was not detected in BL-2 cells under similar culture conditions (Fig. 3) .
Imm-H Inhibits Activated Normal Peripheral Blood T Lymphocytes.
The effect of Imm-H on normal human T cells was determined by in vitro culture in the presence of dGuo and variable concentrations of Imm-H. Peripheral blood T cells were derived from normal donors by negative selection to obtain a pure population of CD3 ϩ lymphocytes (Ͼ99%). Exposure to increasing concentrations of Imm-H had no effect on the viability of unstimulated T cells after 3 days of culture (Fig. 4A) . However, activation of the T cells with an anti-CD3 monoclonal antibody and rhIL-2 (20 units͞ml) for 3 days rendered the cells sensitive to Imm-H suppression (Fig. 4A) . When cells were maximally stimulated by prolonged culture (6 days) with autologous monocytic cells and high-dose rhIL-2 (200 units͞ml), treatment with Imm-H resulted in a greater inhibitory effect (95%) with an IC 50 of 5 nM (Fig. 4B) . Growth of unstimulated T cells was unchanged under similar culture conditions (data not shown).
Imm-H Causes the Accumulation of dGTP. PNP normally catabolizes dGuo to 2-deoxyribose-1-phosphate and guanine. When PNP is inhibited, increased intracellular levels of dGTP result from phosphorylation by dCK. Accumulation of dGTP causes allosteric inhibition of ribonucleotide diphosphate reductase, preventing balanced production of deoxynucleotides essential for DNA synthesis. When dGTP levels were measured by HPLC in the Imm-H sensitive CCRF-CEM cell line exposed to dGuo alone, only GTP was detected. However, in cells exposed to dGuo and Imm-H, dGTP was elevated, and the level of GTP was reduced ( Table 2) . The site of Imm-H action was established by measuring the incorporation of precursors into RNA and DNA. CCRF-CEM cells were exposed briefly to Imm-H without dGuo followed by the addition of radiolabeled guanine, dCyd, adenine, adenosine, or guanosine. Under these conditions, ribonucleotide diphosphate reductase is not inhibited because dGTP does not accumulate. Imm-H suppressed only the incorporation of guanosine into nucleic acids ( Fig. 5 ) with no effect on adenine and guanine phosphoribosyltransferases, dCK, adenosine kinase, or the enzymes of RNA and DNA synthesis, consistent with selective inhibition of PNP. Imm-H bears close structural similarity to inosine and may inhibit oligonucleotide synthesis through incorporation into DNA. This particular case was excluded by demonstrating the lack of incorporation of [2-
C]Imm-H into oligonucleotides (data not shown).
Imm-H Toxicity Correlates with dCK Activity. Imm-H toxicity requires the conversion of dGuo to dGTP, therefore the enzymes involved in dGuo metabolism were evaluated, namely dCK and cytoplasmic 5Ј-nucleotidase (5Ј-NT, EC 3.1.3.5). dCK activity was assayed in cell extracts by using an assay based on the conversion of [ (Fig. 6) . Of the normal human T cells, only the activated T cells were sensitive to suppression by Imm-H. Activated cells consistently showed an increase in dCK compared with unstimulated T cells that were not affected by Imm-H. 5Ј-NT activity did not significantly correlate with Imm-H sensitivity in any of the cell lines tested and did not vary by more than 50% (data not shown).
Discussion
Human genetic deficiency of PNP provides unequivocal evidence that loss of this enzymatic activity causes suppression of T cell function with minimal effects on B cells or other tissues (1) . The challenge of inhibitor design for PNP arises from the abundance of the enzyme in human tissues. Individuals with genetic deficiencies of PNP that retain as little as 5% of normal catalytic activity do not exhibit manifestations of T cell deficiency and do not accumulate circulating dGuo (4, 19) . Therefore, nearly complete inhibition of PNP (Ͼ95%) must be achieved to increase the dGuo concentration to the level required for T cell toxicity (4, 19) . Paradoxically, inhibition of PNP also causes accumulation of PNP substrates, which further increases the requirement for the inhibitor. A similar competition has been seen with inhibitors directed against dihydrofolate reductase (20) . This requirement for near-complete PNP inhibition has prevented the practical success of previous agents Imm-H binds Ϸ1,000 times more tightly to PNP than previous inhibitors and provides inhibition of catalytic activity when only one of the three identical catalytic sites is filled (6) . For instance, the IC 50 of Imm-H is 60-4,000 times lower than those for six other PNP inhibitors against cultured CCRF-CEM cells (4) . We show here that Imm-H is a potent cytotoxic agent against T cells and that this cytotoxicity requires dGuo, which is linked to dGTP accumulation (21) (22) . § ¶ Not detectable (limit of detection ϭ 0.2 and 0.08, respectively). Accumulation of dGTP in T cells causes allosteric inhibition of ribonucleotide diphosphate reductase (Fig. 7) , an activity essential for DNA production in the clonal expansion required in response to an antigenic challenge (22) . Cells resistant to anti-PNP agents may not accumulate dGTP because of decreased dGuo uptake, low dCK activity, and͞or increased dGMP phosphatase activity. The levels of dCK activity were low in the Imm-H-resistant GEO and Jurkat cell line but were elevated in the BL-2 B cell leukemia line. Thus, increased dCK activity or T cell lineage alone is insufficient to predict Imm-H susceptibility. Other mechanisms that limit the accumulation of dGTP may include reduced dGuo transport or high ecto-5Ј-NT activity. In fact, B lymphoblasts have been reported to contain higher levels of ecto-5Ј-NT than T lymphoblasts (23) . In one case, a patient was found to have variable immunodeficiency related to partial deficiencies of both PNP and ecto-5Ј-NT activity (24) , implicating a role of ecto-5Ј-NT in modulating the impact of PNP deficiency.
An important finding was that Imm-H and dGuo had no toxic effect on normal unstimulated peripheral T cells but markedly suppressed the proliferation of activated T cells. Hence, Imm-H is likely to produce a selective inhibitory effect on T cells activated in autoimmune diseases, transplantation, and graftversus-host disease (25) . Imm-H may be especially beneficial in diseases caused by a select population of activated T cells, such as acute graft rejection, or for ex vivo depletion of donor T cells before organ transplantation (26) . In summary, Imm-H is a powerful and selective agent that suppresses the growth of T cell leukemia cell lines as well as activated normal human peripheral T lymphocytes. These effects depended on the presence of dGuo and could be reversed by the addition of dCyd, supporting the mechanism of T cell growth inhibition as caused by accumulation of dGTP, the subsequent block in DNA synthesis and induction of apoptosis. Sensitivity to Imm-H also correlated with increased dCK activity in the T cell leukemia cell lines and activated peripheral T cells. These results suggest that Imm-H may be useful for the treatment of human T cell leukemias and lymphomas and the treatment of diseases characterized by activated T cell responses, such as autoimmunity, organ transplantation, and graft-versus-host disease. Fig. 7 . Proposed mechanism of dGuo toxicity in PNP deficiency. DNA recycling and cellular uptake of plasma dGuo in the absence of PNP activity causes elevated intracellular levels. dGuo is phosphorylated by dCK in cells with high dCK activity, leading to high levels of dGTP that inhibit ribonucleotide diphosphate reductase.
